Regulation of nitric oxide and soluble guanylyl cyclase

Brain Research Bulletin

Volumn 62, Issue 6, 2004, Pages 505-515

  Krumenacker, Joshua S ^a   Hanafy, Khalid A ^a   Murad, Ferid ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Expression; Nitric oxide (NO); Regulation; Soluble guanylyl cyclase (sGC)

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NERVE GROWTH FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN DERIVATIVE;

CONFERENCE PAPER; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; GENE LOCATION; GENOME; HUMAN; IMMUNOBLOTTING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NITRATION; NITROSATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SOLUBILITY; STRUCTURE ANALYSIS;

EID: 1342333897     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00102-3     Document Type: Conference Paper

References (132)

1. Ashman D.F., Lipton R., Melicow M.M., Price T.D. Isolation of adenosine 3′:5′ monophosphate and guanosine 3′:5′-monophosphate from rat urine. Biochem. Biophys. Res. Commun. 11:1963;330-334.
2. Aszodi A., Pfeifer A., Ahmad M., Glauner M., Zhou X.H., Ny L., Andersson K.E., Kehrel B., Offermanns S., Fassler R. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J. 18:1999;37-48.
3. Azam M., Gupta G., Chen W., Wellington S., Warburton D., Danziger R.S. Genetic mapping of soluble guanylyl cyclase genes: implications for linkage to blood pressure in the Dahl rat. Hypertension. 32:1998;149-154.
4. Balabanli B., Kamisaki Y., Martin E., Murad F. Requirements for heme and thiols for the nonenzymatic modification of nitrotyrosine. Proc. Natl. Acad. Sci. U.S.A. 9:1999;13136-13141.
5. Balciuniene J., Johansson K., Sandgren O., Wachtmeister L., Holmgren G., Forsman K. A gene for autosomal dominant progressive cone dystrophy (CORD5) maps to chromosome 17p12-p13. Genomics. 30:1995;281-286.
6. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
7. Behrends S., Harteneck C., Schultz G., Koesling D. A variant of the alpha 2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein. J. Biol. Chem. 270:1995;21109-21113.
8. Behrends S., Kazmierczak B., Steenpa A., Knauf B., Bullerdiek J., Scholz H., Eiberg H. Assignment of GUCY1B2, the gene coding for the beta2 subunit of human guanylyl cyclase to chromosomal band 13q14.3 between markers D13S168 and D13S155. Genomics. 55:1999;126-127.
9. Behrends S., Steenpass A., Porst H., Scholz H. Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum. Biochem. Pharmacol. 59:2000;713-717.
10. Biel M., Seeliger M., Pfeifer A., Kohler K., Gerstner A., Ludwig A., Jaissle G., Fauser S., Zrenner E., Hofmann F. Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7553-7557.
11. Bloch K.D., Filippov G., Sanchez L.S., Nakane M., de la Monte S.M. Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period. Am. J. Physiol. 272:1997;L400-L406.
12. Boolell M., Allen M.J., Ballard S.A., Gepi-Attee S., Muirhead G.J., Naylor A.M., Osterloh I.H., Gingell C. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int. J. Impot. Res. 8:1996;47-52.
13. Bredt S., Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron. 8:1992;3-11.
14. Budworth J., Meillerais S., Charles I., Powell K. Tissue distribution of the human soluble guanylate cyclases. Biochem. Biophys. Res. Commun. 263:1999;696-701.
15. Buechler W.A., Nakane M., Murad F. Expression of soluble guanylate cyclase activity requires both enzyme subunits. Biochem. Biophys. Res. Commun. 174:1991;351-357.
16. Caccone A., Garcia B.A., Mathiopoulos K.D., Min G.S., Moriyama E.N., Powell J.R. Characterization of the soluble guanylyl cyclase beta-subunit gene in the mosquito Anopheles gambiae. Insect. Mol. Biol. 8:1999;23-30.
17. Chhajlani V., Frandberg P.A., Ahlner J., Axelsson K.L., Wikberg J.E. Heterogeneity in human soluble guanylate cyclase due to alternative splicing. FEBS Lett. 290:1991;157-158.
18. Crepel F., Jaillard D. Protein kinases, nitric oxide and long-term depression of synapses in the cerebellum. Neuroreport. 1:1990;133-136.
19. Davis K.L., Martin E., Turko I.V., Murad F. Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 41:2001;203-236.
20. Deguchi T., Yoshioka M. L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. J. Biol. Chem. 257:1982;10147-10151.
21. Deng A.Y., Dene H., Pravenec M., Rapp J.P. Genetic mapping of two new blood pressure quantitative trait loci in the rat by genotyping endothelin system genes. J. Clin. Invest. 93:1994;2701-2709.
22. Deng A.Y., Dene H., Rapp J.P. Mapping of a quantitative trait locus for blood pressure on rat chromosome 2. J. Clin. Invest. 94:1994;431-436.
23. Deng A.Y., Dene H., Rapp J.P. Congenic strains for the blood pressure quantitative trait locus on rat chromosome 2. Hypertension. 30:1997;199-202.
24. Endo S., Suzuki M., Sumi M., Nairn A.C., Morita R., Yamakawa K., Greengard P., Ito M. Molecular identification of human G-substrate, a possible downstream component of the cGMP-dependent protein kinase cascade in cerebellar Purkinje cells. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2467-2472.
25. Fedele E., Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog. Neurobiol. 58:1999;89-120.
26. Filippov G., Bloch D.B., Bloch K.D. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J. Clin. Invest. 100:1997;942-948.
27. Foerster J., Harteneck C., Malkewitz J., Schultz G., Koesling D. A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. Eur. J. Biochem. 240:1996;380-386.
28. Friebe A., Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53:1998;123-127.
29. Friebe A., Wedel B., Harteneck C., Foerster J., Schultz G., Koesling D. Functions of conserved cysteines of soluble guanylyl cyclase. Biochemistry. 36:1997;1194-1198.
30. B. Gaston, J.S. Stamler, Biochemistry of Nitric Oxide, Nitric Oxide and Infection, Kluwer Academic/Plenum Publishers, Dordrecht/New York, 1999, pp. 37-55.
31. Gibbs S.M., Truman J.W. Nitric oxide and cyclic GMP regulate retinal patterning in the optic lobe of Drosophila. Neuron. 20:1998;83-93.
32. Giuili G., Roechel N., Scholl U., Mattei M.G., Guellaen G. Colocalization of the genes coding for the alpha 3 and beta 3 subunits of soluble guanylyl cyclase to human chromosome 4 at q31.3-q33a. Hum. Genet. 91:1993;91257-91260.
33. Gow A.J., Duran D., Malcolm S., Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett. 385:1996;63-66.
34. Guimaraes C., Assreuy J., Linden R. Paracrine neuroprotective effect of nitric oxide in the developing retina. J. Neurochem. 76:2001;1233-1241.
35. Gupta G., Azam M., Yang L., Danziger R.S. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J. Clin. Invest. 100:1997;1488-1492.
36. Hanafy K.A., Krumenacker J.S., Murad F. NO, nitrotyrosine and cGMP in signal transduction. Med. Sci. Monit. 7:2001;801-819.
37. Hardman J.G., Sutherland E.W. Guanylyl cyclase, an enzyme catalyzing the formation of guanosine 3′,5′-monophosphate from guanosine triphosphate. J. Biol. Chem. 244:1969;6363-6370.
38. Harteneck C., Wedel B., Koesling D., Malkewitz J., Bohme E., Schultz G. Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Lett. 292:1991;217-222.
39. Haynes M.P., Sinha D., Russell K.S., Collinge M., Fulton D., Morales-Ruiz M., Sessa W.C., Bender J.R. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87:2000;677-682.
40. Hibbs J.B. Jr., Taintor R.R., Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 235:1987;473-476.
41. Hobbs A.J. Soluble guanylate cyclase: the forgotten sibling. Trends Pharmacol. Sci. 18:1997;484-491.
42. Hughes A.E., Lotery A.J., Silvestri G. Fine localisation of the gene for central areolar choroidal dystrophy on chromosome 17p. J. Med. Genet. 35:1998;770-772.
43. Huie R.E., Padmaja S. The reaction of NO with superoxide. Free Radic. Res. Commun. 18:1993;195-199.
44. Humbert P., Niroomand F., Fischer G., Mayer B., Koesling D., Hinsch K.D., Gausepohl H., Frank R., Schultz G., Bohme E. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur. J. Biochem. 190:1990;273-278.
45. Idriss S.D., Gudi T., Casteel D.E., Kharitonov V.G., Pilz R.B., Boss G.R. Nitric oxide regulation of gene transcription via soluble guanylate cyclase and type I cGMP-dependent protein kinase. J. Biol. Chem. 274:1999;9489-9493.
46. Ignarro L.J., Degnan J.N., Baricos W.H., Kadowitz P.J., Wolin M.S. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta. 718:1982;49-59.
47. Itoh H., Bird I.M., Nakao K., Magness R.R. Pregnancy increases soluble and particulate guanylate cyclases and decreases the clearance receptor of natriuretic peptides in ovine uterine, but not systemic, arteries. Endocrinology. 139:1998;3329-3341.
48. Jarchau T., Hausler C., Markert T., Pohler D., Vanderkerckhove J., De Jonge H.R., Lohmann S.M., Walter U. Cloning, expression, and in situ localization of rat intestinal cGMP-dependent protein kinase II. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9426-9430.
49. Kamisaki Y., Saheki S., Nakane M., Palmieri J.A., Kuno T., Chang B.Y., Waldman S.A., Murad F. Soluble guanylate cyclase from rat lung exists as a heterodimer. J. Biol. Chem. 261:1986;7236-7241.
50. Kamisaki Y., Wada K., Bian K., Balabanli B., Davis K., Martin E., Behbod F., Lee Y.C., Murad F. An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc. Natl. Acad. Sci. U.S.A. 29:1998;11584-11589.
51. Katsuki S., Arnold W., Mittal C., Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3:1977;23-35.
52. Kelly M.J., Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12:2001;12152-12156.
53. Kelsell R.E., Gregory-Evans K., Payne A.M., Perrault I., Kaplan J., Yang R.B., Garbers D.L., Bird A.C., Moore A.T., Hunt D.M. Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum. Mol. Genet. 7:1998;1179-1184.
54. Kimura H., Mittal C.K., Murad F. Activation of guanylate cyclase from rat liver and other tissues by sodium azide. J. Biol. Chem. 250:1975;8016-8022.
55. Kimura H., Murad F. Two forms of guanylate cyclase in mammalian tissues and possible mechanisms for their regulation. Metabolism. 24:1975;439-445.
56. Kishimoto I., Dubois S.K., Garbers D.L. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6215-6219.
57. Klatt P., Molina E.P., Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J. Biol. Chem. 274:1999;15857-15864.
58. Kloss S., Bouloumie A., Mulsch A. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension. 35:2000;43-47.
59. Koesling D. Studying the structure and regulation of soluble guanylyl cyclase. Methods. 19:1999;485-493.
60. Kojima M., Hisaki K., Matsuo H., Kangawa K. A new type soluble guanylyl cyclase, which contains a kinase-like domain: its structure and expression. Biochem. Biophys. Res. Commun. 217:1995;993-1000.
61. Komalavilas P., Lincoln T.M. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J. Biol. Chem. 269:1994;8701-8707.
62. Koss M.C. Functional role of nitric oxide in regulation of ocular blood flow. Eur. J. Pharmacol. 374:1999;161-174.
63. Krumenacker J.S., Hyder S.M., Murad F. Estradiol rapidly inhibits soluble guanylyl cyclase expression in rat uterus. Proc. Natl. Acad. Sci. U.S.A. 98:2001;717-722.
64. Krupinski J., Coussen F., Bakalyar H.A., Tang W.J., Feinstein P.G., Orth K., Slaughter C., Reed R.R., Gilman A.G. Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. Science. 244:1989;1558-1564.
65. Lacaille J.C., Dunkel D.D., Schwartzkroin P.A. Electrophysiological and morphological characterization of hippocampal interneurons. The Hippocampus-New Vistas. 52:1989;287-305.
66. Lander H.M., Ogiste J.S., Pearce S.F., Levi R., Novodrodsky A. Nitric oxide-stimulated guanine nucleotide exchange on p21ras. J. Biol. Chem. 270:1995;7017-7020.
67. Lee Y.C., Martin E., Murad F. Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10763-10768.
68. Lincoln T.M., Komalavilas P., Boerth N.J., MacMillan-Crow L.A., Cornwell T.L. cGMP signaling through cAMP- and cGMP-dependent protein kinases. Adv. Pharmacol. 34:1995;305-322.
69. Liu H., Force T., Bloch K.D. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells. J. Biol. Chem. 272:1997;6038-6043.
70. Liu L., Hausladen A., Zeng M., Que L., Heitman J., Stamler J.S. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature. 410:2001;490-494.
71. Lohmann S.M., Vaandrager A.B., Smolenski A., Walter U., De Jonge H.R. Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem. Sci. 22:1997;307-312.
72. Lopez M.J., Wong S.K., Kishimoto I., Dubois S., Mach V., Friesen J., Garbers D.L., Beuve A. Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature. 378:1995;65-68.
73. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52:2000;375-414.
74. Mann E.A., Jump M.L., Wu J., Yee E., Giannella R.A. Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion. Biochem. Biophys. Res. Commun. 239:1997;463-466.
75. Marletta M.A. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 78:1994;927-930.
76. Matthews J.R., Botting C.H., Panico M., Morris H.R., Hay R.T. Inhibition of NF-κB DNA binding by nitric oxide. Nucleic Acids Res. 24:1996;2236-2242.
77. Mikami T., Kusakabe T., Suzuki N. Tandem organization of medaka fish soluble guanylyl cyclase alpha1 and beta1 subunit genes. Implications for coordinated transcription of two subunit genes. J. Biol. Chem. 274:1999;18567-18573.
78. Nakane M., Arai K., Saheki S., Kuno T., Buechler W., Murad F. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung. J. Biol. Chem. 265:1990;16841-16845.
79. Nakane M., Saheki S., Kuno T., Ishii K., Murad F. Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung. Biochem. Biophys. Res. Commun. 157:1988;1139-1147.
80. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
81. Nathan C., Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
82. Nathanson J.A., McKee M. Alterations of ocular nitric oxide synthase in human glaucoma. Invest. Ophthalmol. Vis. Sci. 36:1995;1774-1784.
83. Neufeld A.H. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration. J. Glaucoma. 7:1998;434-438.
84. Neufeld A.H., Hernandez M.R., Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. 115:1997;497-503.
85. Neufeld A.H., Sawada A., Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U.S.A. 96:1999;9944-9948.
86. Nighorn A., Byrnes K.A., Morton D.B. Identification and characterization of a novel beta subunit of soluble guanylyl cyclase that is active in the absence of a second subunit and is relatively insensitive to nitric oxide. J. Biol. Chem. 274:1999;2525-2531.
87. Oliver P.M., Fox J.E., Kim R., Rockman H.A., Kim H.S., Reddick R.L., Pandey K.N., Milgram S.L., Smithies O., Maeda N. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14730-14735.
88. Orstavik S., Solberg R., Tasken K., Nordahl M., Altherr M.R., Hansson V., Jahnsen T., Sandberg M. Molecular cloning, cDNA structure, and chromosomal localization of the human type II cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 220:1996;759-765.
89. Papapetropoulos A., Marczin N., Mora G., Milici A., Murad F., Catravas J.D. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension. 26:1995;696-704.
90. Perrault I., Rozet J.M., Calvas P., Gerber S., Camuzat A., Dollfus H., Chatelin S., Souied E., Ghazi I., Leowski C., Bonnemaison M., Le Paslier D., Frezal J., Dufier J.L., Pittler S., Munnich A., Kaplan J. Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nat. Genet. 14:1996;461-464.
91. Pollock J.S., Fostermann U., Mitchell J.A., Warner T.D., Schmidt H.H., Nakane M., Murad F. Purification and characterization of particulate EDRF synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10480-10484.
92. Pryzwansky K.B., Wyatt T.A., Lincoln T.M. Cyclic guanosine monophosphate-dependent protein kinase is targeted to intermediate filaments and phosphorylates vimentin in A23187-stimulated human neutrophils. Blood. 85:1995;222-230.
93. Quigley H.A., Enger C., Katz J., Sommer A., Scott R., Gilbert D. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch. Ophthalmol. 112:1994;644-649.
94. 2+ pump of bovine pulmonary artery. Cell Calcium. 11:1990;261-268.
95. Rapoport R., Murad F. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. J. Cyclic Nucleotide Protein Phosphorylation Res. 9:1983;281-296.
96. Ritter D., Taylor J.F., Hoffmann J.W., Carnaghi L., Giddings S.J., Zakeri H., Kwok P.Y. Alternative splicing for the alpha1 subunit of soluble guanylate cyclase. Biochem. J. 346:2000;811-816.
97. Ruetten H., Zabel U., Linz W., Schmidt H.H. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ. Res. 85:1999;534-541.
98. Russwurm M., Behrends S., Harteneck C., Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 335:1998;125-130.
99. A. Savchenko, T.W. Kraft, E. Molokanova, R.H. Kramer, Growth factors regulate phototransduction in retinal rods by modulating cyclic nucleotide-gated channels through dephosphorylation of a specific tyrosine residue, Proc. Natl. Acad. Sci. U.S.A. (2001) (epub ahead of print).
100. Schmidt H.H., Walter U. NO at work. Cell. 78:1994;919-925.
101. Schoser B.G., Behrends S. Soluble guanylyl cyclase is localized at the neuromuscular junction in human skeletal muscle. Neuroreport. 12:2001;979-981.
102. Schulz S., Lopez M.J., Kuhn M., Garbers D.L. Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J. Clin. Invest. 100:1997;1590-1595.
103. Schuman J.S., Erickson K., Nathanson J.A. Nitrovasodilator effects on intraocular pressure and outflow facility in monkeys. Exp. Eye Res. 58:1994;99-105.
104. Scott W.S., Nakayama D.K. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. J. Surg. Res. 80:1998;309-314.
105. Shareef S., Sawada A., Neufeld A.H. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 40:1999;2884-2891.
106. Sharina I.G., Krumenacker J.S., Martin E., Murad F. Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10878-10883.
107. Shimouchi A., Janssens S.P., Bloch D.B., Zapol W.M., Bloch K.D. cAMP regulates soluble guanylate cyclase beta 1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am. J. Physiol. 265:1993;L456-L461.
108. Simpson P.J., Nighorn A., Morton D.B. Identification of a novel guanylyl cyclase that is related to receptor guanylyl cyclases, but lacks extracellular and transmembrane domains. J. Biol. Chem. 274:1999;4440-4446.
109. Sloviter R.S. Feedforward and feedback inhibition of hippocampal principal cell activity evoked by perforant path stimulation: GABA-mediated mechanisms that regulate excitability in vivo. Hippocampus. 1:1991;31-40.
110. Stasch J.P., Becker E.M., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Gerzer R., Minuth T., Perzborn E., Pleiss U., Schroder H., Schroeder W., Stahl E., Steinke W., Straub A., Schramm M. NO-independent regulatory site on soluble guanylate cyclase. Nature. 410:2001;212-215.
111. Stone J.R., Marletta M.A. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry. 33:1994;5636-5640.
112. Sunahara R.K., Beuve A., Tesmer J.J., Sprang S.R., Garbers D.L., Gilman A.G. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases. J. Biol. Chem. 273:1998;16332-16338.
113. Surks H.K., Mochizuki N., Kasai Y., Georgescu S.P., Tang K.M., Ito M., Lincoln T.M., Mendelsohn M.E. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science. 286:1999;1583-1587.
114. Takata M., Filippov G., Liu H., Ichinose F., Janssens S., Bloch D.B., Bloch K.D. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L272-L278.
115. Tamura N., Itoh H., Ogawa Y., Nakagawa O., Harada M., Chun T.H., Suga S., Yoshimasa T., Nakao K. cDNA cloning and gene expression of human type Ialpha cGMP-dependent protein kinase. Hypertension. 27:1996;552-557.
116. Thorpe D.S., Garbers D.L. The membrane form of guanylate cyclase. Homology with a subunit of the cytoplasmic form of the enzyme. J. Biol. Chem. 264:1989;6545-6549.
117. Uhler M.D. Cloning and expression of a novel cyclic GMP-dependent protein kinase from mouse brain. J. Biol. Chem. 268:1993;13586-13591.
118. Varol F.G., Duchemin A.M., Neff N.H., Hadjiconstantinou M. Nerve growth factor (NGF) and NGF mRNA change in rat uterus during pregnancy. Neurosci. Lett. 294:2000;58-62.
119. 2+-ATPase in skeletal muscle. Biochem. J. 340:1999;657-669.
120. Walter U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev. Physiol. Biochem. Pharmacol. 113:1989;42-88.
121. Wedel B., Garbers D. The guanylyl cyclase family at y2k. Annu. Rev. Physiol. 63:2001;215-233.
122. Wedel B., Harteneck C., Foerster J., Friebe A., Schultz G., Koesling D. Functional domains of soluble guanylyl cyclase. J. Biol. Chem. 270:1995;24871-24875.
123. Wedel B., Humbert P., Harteneck C., Foerster J., Malkewitz J., Bohme E., Schultz G., Koesling D. Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2592-2596.
124. Wiederholt M., Sturm A., Lepple-Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest. Ophthalmol. Vis. Sci. 35:1994;2515-2520.
125. Wilson E.M., Chinkers M. Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry. 34:1995;4696-4701.
126. Xu L., Eu J.P., Meissner G., Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science. 279:1998;234-237.
127. Yamakura F., Taka H., Fujimura T., Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem. 273:1998;14085- 14089.
128. Yuen P.S., Potter L.R., Garbers D.L. A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry. 29:1990;10872-10878.
129. Zabel U., Hausler C., Weeger M., Schmidt H.H. Homodimerization of soluble guanylyl cyclase subunits. Dimerization analysis using a glutathione S-transferase affinity tag. J. Biol. Chem. 274:1999;18149-18152.
130. Zhao Y., Brandish P.E., DiValentin M., Schelvis J.P., Babcock G.T., Marletta M.A. Inhibition of soluble guanylate cyclase by ODQ. Biochemistry. 39:2000;10848-10854.
131. Zhuo M., Hawkins R. Long-term depression: a learning-related type of synaptic plasticity in the mammalian central nervous system. Rev. Neurosci. 6:1995;259-277.
132. Zou M.H., Klein T., Pasquet J.P., Ullrich V. Interleukin 1beta decreases prostacyclin synthase activity in rat mesangial cells via endogenous peroxynitrite formation. Biochem. J. 336:1998;507-512.